Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 11/20 | 0.51 |
| ▸ | GRIA2 | P42262 | 11/20 | 0.51 |
| ▸ | GRIA3 | P42263 | 11/20 | 0.51 |
| ▸ | GRIA4 | P48058 | 11/20 | 0.51 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.51 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.51 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.51 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.51 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.51 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.51 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.51 |
| ▸ | GRIK1 | P39086 | 5/20 | 0.48 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.48 |
| ▸ | GRIK3 | Q13003 | 5/20 | 0.48 |
| ▸ | GRIK4 | Q16099 | 5/20 | 0.48 |
| ▸ | GRIK5 | Q16478 | 5/20 | 0.48 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fanapanel SCHEMBL353357 | 1.00 | GRIA1 (0.51) | GRIA1GRIA2GRIA3GRIA4GRIN2D | |
| Fanapanel SCHEMBL30546194 | 0.99 | GRIA1 (0.50) | GRIA1GRIA2GRIA3GRIA4GRIN2D | |
| Fanapanel SCHEMBL25432377 | 0.99 | GRIA1 (0.50) | GRIA1GRIA2GRIA3GRIA4GRIN2D | |
| SCHEMBL8107335 | 0.90 | GRIA1 (0.53) | GRIA1GRIA2GRIA3GRIA4GRIN2D | |
| SCHEMBL8122798 | 0.90 | GRIA1 (0.53) | GRIA1GRIA2GRIA3GRIA4GRIN2D | |
| SCHEMBL8340446 | 0.87 | GRIA1 (0.50) | GRIA1GRIA2GRIA3GRIA4GRIN2D | |
| SCHEMBL7088166 | 0.86 | GRIA1 (0.47) | GRIA1GRIA2GRIA3GRIA4GRIN2D | |
| SCHEMBL2037840 | 0.86 | GRIA1 (0.49) | GRIA1GRIA2GRIA3GRIA4GRIN2D | |
| SCHEMBL8341491 | 0.85 | GRIA1 (0.43) | GRIA1GRIA2GRIA3GRIA4GRIN2D | |
| SCHEMBL7885810 | 0.84 | GRIA1 (0.48) | GRIA1GRIA2GRIA3GRIA4GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4475953-A1 | NMDAR ANTAGONISTS PREVENT AGEING AND AGING-ASSOCIATED CONDITIONS AND DISEASES THROUGH INCREASING 20S PROTEASOME ACTIVITY | SAHIN, Fikret (TR) | 2024-12-18 | — | — | EP | claimed |
| CN-119095622-A | NMDAR antagonists prevent aging and aging-related conditions and diseases by increasing 20S proteasome activity | 菲克雷特·萨欣 | 2024-12-06 | — | — | CN | claimed |
| WO-2023154014-A1 | NMDAR ANTAGONISTS PREVENT AGEING AND AGING-ASSOCIATED CONDITIONS AND DISEASES THROUGH INCREASING 20S PROTEASOME ACTIVITY | SAHIN FIKRET (TR) | 2023-08-17 | — | — | WO | claimed |
| US-12616807-B2 | Medical counter measures including dry powder formulations and associated methods | Belhaven BioPharma Inc. (US) | 2026-05-05 | — | — | US | disclosed |
| US-20250288544-A1 | PROBENECID FOR USE IN TREATING EPILEPTIC DISEASES, DISORDERS OR CONDITIONS | PARIS SCIENCES ET LETTRES - QUARTIER LATIN (FR) | 2025-09-18 | — | — | US | disclosed |
| US-20250281474-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING COGNITIVE DECLINE OR FOR TREATING OVERWEIGHTNESS OR OBESITY | UNIVERSITY OF THE RYUKYUS (JP) | 2025-09-11 | — | — | US | disclosed |
| US-12370233-B2 | Depot systems comprising glatiramer acetate | MAPI PHARMA LTD. (IL) | 2025-07-29 | — | — | US | disclosed |
| CN-114614625-B | Efficient and energy-saving heat dissipation device for variable frequency motor | 马勇 | 2025-06-24 | — | — | CN | disclosed |
| US-12318358-B2 | Probenecid for use in treating epileptic diseases, disorders or conditions | PARIS SCIENCES ET LETTRES (FR) | 2025-06-03 | — | — | US | disclosed |
| US-20250161238-A1 | NMDAR Antagonists Prevent Ageing and Aging-Associated Conditions and Diseases Through Increasing 20S Proteasome Activity | SAHIN FIKRET (TR) | 2025-05-22 | — | — | US | disclosed |
| US-12297997-B1 | Fan lamp | Yu Huanyuan (CN) | 2025-05-13 | — | — | US | disclosed |
| CN-113955230-B | Intelligent processing method and production line of camel fresh milk | 阿拉善左旗梦可草原牧业食品专业合作社 | 2023-03-17 | — | — | CN | disclosed |
| WO-2023010713-A1 | TEMPERATURE-COMPENSATION-TYPE AIR-COOLED OIL COOLER | 浙江尔格科技股份有限公司 | 2023-02-09 | — | — | WO | disclosed |
| US-11490856-B2 | Method and a system for analyzing neuropharmacology of a drug | CITY UNIVERSITY OF HONG KONG (HK) | 2022-11-08 | — | — | US | disclosed |
| CN-216812298-U | Fan installation jig | 浙江日风电气股份有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-114614625-A | Efficient and energy-saving heat dissipation device for variable frequency motor | 马勇 | 2022-06-10 | — | — | CN | disclosed |
| CN-114263080-A | High-pressure flushing and dredging device for sewage pipeline | 苏州净沐环保科技有限公司 | 2022-04-01 | — | — | CN | disclosed |
| US-20220047505-A1 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | STI PHARMA, LLC (US) | 2022-02-17 | — | — | US | disclosed |
| CN-215809467-U | Ultralow-temperature drug storage evaporator | 济南康斐净化技术有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-113955230-A | Intelligent processing method and production line of camel fresh milk | 阿拉善左旗梦可草原牧业食品专业合作社 | 2022-01-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250288544-A1 | PROBENECID FOR USE IN TREATING EPILEPTIC DISEASES, DISORDERS OR CONDITIONS | NLN, CLN6, SLC1A2 | GRIA1 346/4885GRIA2 127/4885GRIA3 170/4885 |
| US-12616807-B2 | Medical counter measures including dry powder formulations and associated methods | ADRB2, ADRB3, MC5R | GRIA1 1312/4885GRIA2 1365/4885GRIA3 1422/4885 |
| US-12318358-B2 | Probenecid for use in treating epileptic diseases, disorders or conditions | NLN, CLN6, SLC1A2 | GRIA1 346/4885GRIA2 127/4885GRIA3 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.